» Articles » PMID: 21136957

The Use of Phosphate-affinity SDS-PAGE to Measure the Cardiac Troponin I Phosphorylation Site Distribution in Human Heart Muscle

Overview
Specialty Biochemistry
Date 2010 Dec 8
PMID 21136957
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

We have used phosphate affinity SDS-PAGE to separate the phosphorylated species of cardiac troponin I (cTnI). To test the method we phosphorylated pure cTnI with protein kinase A catalytic subunit and observed up to six bands corresponding to 0, 1P, 2P, 3P, 4P and 5P phospho-species. We examined the phospho-species of cTnI in human heart myofibrillar extracts by phosphate affinity SDS-PAGE and Western blotting with a non-specific troponin I (TnI) antibody. In donor heart samples the bis-phosphorylated species of cTnI predominated and no more highly phosphorylated species were not detectable (0P was 10.3±1.9%, 1P, 17.5±3.5%, 2P, 72.2±4.7%, 11 samples). Total phosphorylation was 1.62±0.06 molsPi/mol TnI. In myofibrils from end-stage failing hearts, the unphosphorylated cTnI species predominated (0P was 78.5±1.8%, 1P, 17.5±1.9%, 2P, 4.0±0.7%, total phosphorylation 0.26±0.02 molsPi/mol TnI, five samples). Muscle from patients with hypertrophic obstructive cardiomyopathy was also largely unphosphorylated (0P was 76.6±3.1%, 1P, 17.5±2.7%, 2P, 5.9±0.8%, total phosphorylation 0.29±0.04 molsPi/mol TnI, 19 samples). Using a range of phospho-specific antibodies we demonstrated that 3/4 of the bis-phosphorylated band of donor heart cTnI is phosphorylated at Ser22 and Ser23 in approximately equal amounts and that phosphorylation of Ser43 and Thr142 was not detected.

Citing Articles

The Acute Effects of Leptin on the Contractility of Isolated Rat Atrial and Ventricular Cardiomyocytes.

Khokhlova A, Myachina T, Butova X, Kochurova A, Polyakova E, Galagudza M Int J Mol Sci. 2022; 23(15).

PMID: 35955485 PMC: 9369024. DOI: 10.3390/ijms23158356.


Critical Evaluation of Current Hypotheses for the Pathogenesis of Hypertrophic Cardiomyopathy.

Usaj M, Moretto L, Mansson A Int J Mol Sci. 2022; 23(4).

PMID: 35216312 PMC: 8880276. DOI: 10.3390/ijms23042195.


Unraveling the Genotype-Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity-Related Cardiac Defects as a Major Disease Modifier.

Nollet E, Westenbrink B, de Boer R, Kuster D, van der Velden J J Am Heart Assoc. 2020; 9(22):e018641.

PMID: 33174505 PMC: 7763714. DOI: 10.1161/JAHA.120.018641.


Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation.

Vikhorev P, Vikhoreva N, Yeung W, Li A, Lal S, Dos Remedios C Cardiovasc Res. 2020; 118(1):241-253.

PMID: 33135063 PMC: 8752363. DOI: 10.1093/cvr/cvaa316.


Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics.

Tucholski T, Cai W, Gregorich Z, Bayne E, Mitchell S, Mcilwain S Proc Natl Acad Sci U S A. 2020; 117(40):24691-24700.

PMID: 32968017 PMC: 7547245. DOI: 10.1073/pnas.2006764117.